|
|
 |
|
Viewing report
|
|
|
|
Phosphatases: Emerging Role in Signal Transduction, Human Therapeutics, & As Drug Targets
Drug and Market Development Publishing, Feb 2004
Recently, several members of the phosphatase drug target class have been identified and classes of compounds have been screened with hits identified. This activity has prompted several pharmaceutical companies to devote a portion of their pipelines to the development of this promising class. In particular, a multi-million dollar commitment has been made by companies towards the development of phosphatases shown to be associated with obesity and cancer. ScopeThis Report is the most comprehensive analysis available covering the commercial viability of the phosphatase enzyme class as therapeutic targets. It provides an in-depth analysis of the emerging market for phosphatases. What phosphatases are is clearly defined, including their classification, role in diseases, role in signal transduction, and as potential targets for developing therapeutics. The intellectual property landscape is reviewed, companies invested in phosphatase development are profiled, and key industry players are interviewed.Market Opportunities- Discover and develop therapeutic molecules against phosphatase protein targets through the screening of small molecule libraries. - Develop phosphatase-targeted immunotherapeutics to meet the demands for pioneering and curative drugs to battle high morbidity diseases and high mortality conditions. - Utilize the rapid breakthroughs in the study of phosphatase structures and inhibitors to enable increasingly selective drug targeting. - Capitalize on the niche innovative technologies of small biotechnology companies to fill product pipelines with commercially viable phosphatase-targeted drugs. -Partner with a large pharmaceutical entity to solidify the demand of your niche technology in creating these cutting-edge phosphatase-targeted drugs.Key Reasons to Buy-Pinpoint the full potential of the phosphatases drug target class with an examination of the projected impact across several markets. - Determine the advantage of phosphatases for developing human therapeutics over other known classes of drug targets through a comprehensive breakdown of their classifications, mechanisms, and limitations. - Discover the commercial viability of phosphatases through a detailed analysis of their role in signal transduction and as targets for human therapeutics. - Learn about the current intellectual property landscape via an in-depth review of patents covering phosphatases and their inhibitors. - Gain reliable and thought-provoking insights into the phosphatases market through interviews with authorities involved in this industry. - Look inside companies working within the phosphatases field, including their product pipelines, partnerships & alliances, business strategies, technologies, and more.Companies profiled in this report include: - Ceptyr - ISIS Pharmaceuticals - Serono PRI - Sunesis - Vertex
Customers who bought this item also bought
GPCR - Drug Targets
Biochemistry of Signal Transduction and Regulation, 4th Edition
The Emerging Drug Targets Outlook: An Analysis of Novel Molecular Targets To Develop Innovative New Therapeutics
Preclinical Cancer Therapeutics 2007: Decoding Next Generation Drug Targets for Market Success
Kinases: Advanced Strategies and Multiple Targets for Drug Discovery
The Future of RNAi Therapeutics: Drug Pipelines and Prospects
Patents in the Postgenomic Era: Proprietary Drug Targets and Therapies
The Targeted Cancer Therapies Pipeline: A Strategic Review
The Drug Target Atlas of Protein Kinase Inhibitors in Oncology
Proteases as Drug Targets: Technologies and Opportunities for Drug Discovery
Antiparasitic and Antibacterial Drug Discovery: From Molecular Targets to Drug Candidates
Pain Therapeutics - Drugs, Markets and Companies
|
|
|
|
